NCT05104138View on ClinicalTrials.gov

Eplerenone Versus PDT: Comparative Study by OCTA

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

October 1, 2015

Primary Completion Date

October 30, 2017

Study Completion Date

November 30, 2017

Conditions
Central Serous Chorioretinopathy
Interventions
DRUG

Eplerenone

The patients underwent eplerenone treatment for 6 months

DEVICE

The patients underwent half fluence photodynamic therapy for 6 months

Half fluence photodynamic therapy for 6 months

All Listed Sponsors
lead

Federico II University

OTHER

NCT05104138 - Eplerenone Versus PDT: Comparative Study by OCTA | Biotech Hunter | Biotech Hunter